Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01669
|
|||||
| Drug Name |
Buformin
|
|||||
| Synonyms |
Buformin; 1-Butylbiguanide; Buformine; Butyldiguanide; Butylbiguanide; Butformin; Butylbiguanidum; Glybigid; 1-Butyldiguanide; Glybigidum; N-Butylbiguanide; Buformina; Buforminum; Buformine [INN-French]; Buforminum [INN-Latin]; Buformina [INN-Spanish]; Silubin; Adebit; BIGUANIDE, 1-BUTYL-; Buformin [USAN:INN]; W 37; Buformin HCl; Imidodicarbonimidic diamide, N-butyl-; Sindiatil; Panformin; Diabrin; Biforon; Andere; UNII-W2115E9C7B; Buformine HCl; N-butylimidodicarbonimidic diamide; DBV hydrochloride; H 224
|
|||||
| Indication | Type 2 diabetes [ICD11: 5A11] | Approved | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C6H15N5
|
|||||
| Canonical SMILES |
CCCCN=C(N)N=C(N)N
|
|||||
| InChI |
InChI=1S/C6H15N5/c1-2-3-4-10-6(9)11-5(7)8/h2-4H2,1H3,(H6,7,8,9,10,11)
|
|||||
| InChIKey |
XSEUMFJMFFMCIU-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 692-13-7
|
|||||
| Pharmaceutical Properties | Molecular Weight | 157.22 | Topological Polar Surface Area | 103 | ||
| Heavy Atom Count | 11 | Rotatable Bond Count | 4 | |||
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 1 | |||
| XLogP |
-0.6
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
CHEBI:3209
|
|||||
| DT(s) Transporting This Drug | OCT-1 | Transporter Info | Organic cation transporter 1 | Substrate | [2] | |
| References | ||||||
| 1 | National Center for Advancing Translational Science-Inxight: drug (W2115E9C7B) | |||||
| 2 | Human intestinal transporter database: QSAR modeling and virtual profiling of drug uptake, efflux and interactions. Pharm Res. 2013 Apr;30(4):996-1007. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.